Efficacy and safety of durvalumab plus chemotherapy as neoadjuvant regimen in the treatment of locally advanced non-small cell lung cancer patients
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 9 | 9 |
| PDF downloads | 0 | 0 | 3 | 3 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|